Clozapine and Pneumonia: Synthesizing the Link by Reviewing Existing Reports-A Systematic Review and Meta-Analysis
Victor Zhao1,2, Yiting Gong1, Naveen Thomas2
1Department of Psychiatry, University of Melbourne, Parkville 3052, Australia.
Clozapine, an effective antipsychotic, significantly increases pneumonia risk due to sedation and neutropenia. Prioritizing pneumococcal vaccination for clozapine patients is crucial to reduce pneumonia mortality.
Area of Science:
- Psychiatry and Pharmacology
- Infectious Disease Epidemiology
Background:
- Clozapine is a vital antipsychotic for treatment-resistant disorders but carries a high risk of fatal pneumonia.
- Understanding clozapine-associated pneumonia risk factors and mechanisms is critical for patient safety.
Approach:
- Systematic literature review across five databases adhering to PRISMA guidelines.
- Included peer-reviewed original research on clozapine and pneumonia, excluding case reports.
- Extracted data on participant demographics, pneumonia details, risk factors, and mechanisms.
Key Points:
- Clozapine use is associated with a higher pneumonia risk than other antipsychotics.
- Risk factors include comorbidities, higher dosages, and concurrent antipsychotic use.
- Mechanisms involve clozapine-induced hyper sedation, sialorrhea (excessive salivation), and neutropenia (low white blood cell count).
Conclusions:
- Clozapine, despite improving overall mortality, presents the highest pneumonia risk among antipsychotics.
- Pneumococcal vaccination is underutilized in clozapine users, necessitating increased uptake.
- Enhanced risk assessment and preventative strategies are vital for clozapine-treated patients.
More Related Videos
09:49Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Combined Effects of Drugs: Synergism
Such synergistic combinations...
